Get 20% lifetime commission for referring investors to digrin.com
here.
Avid Bioservices, Inc. (CDMO) Financials
Stock symbol CDMO is outdated, potentially delisted? Maybe it is available on other exchange?
CDMO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| July 31, 2024 | 334.6 million | 276.0 million |
| April 30, 2024 | 336.6 million | 275.7 million |
| Jan. 31, 2024 | 455.2 million | 275.1 million |
| Oct. 31, 2023 | 454.6 million | 271.0 million |
CDMO Free Cash Flow and Stock based compensation
No data available :(
CDMO Net Income
No data available :(
CDMO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| July 31, 2024 | 36.8 million | 204.6 million | 52.1 million |
| April 30, 2024 | 38.1 million | 205.0 million | 52.8 million |
| Jan. 31, 2024 | 35.5 million | 52.2 million | 53.5 million |
| Oct. 31, 2023 | 31.4 million | 52.9 million | 54.1 million |
CDMO Shares Outstanding
CDMO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| July 31, 2024 | 1.3 million | - | 8.2 million | - |
| April 30, 2024 | 5.7 million | - | 6.8 million | 800000 |
| Jan. 31, 2024 | 4.5 million | - | 6.4 million | - |
| Oct. 31, 2023 | 7.3 million | - | 6.6 million | - |
CDMO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| July 31, 2024 | 40.2 million | 34.5 million |
| April 30, 2024 | 43.0 million | 37.5 million |
| Jan. 31, 2024 | 33.8 million | 31.4 million |
| Oct. 31, 2023 | 25.4 million | 30.1 million |
CDMO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CDMO
Price: $12.49
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 451500
Ebitda: -12.0 millionMarket Capitalization: 798.9 million